About
Precision Medicines for Brain Diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
2,365
By Phase
PHASE1: 1PHASE2: 2PHASE3: 4
By Status
RECRUITING: 4COMPLETED: 3
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06546995Lead Sponsor
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
PHASE1Recruiting
96 participants
Started: Jul 9, 2024 · Completed: Nov 30, 2025
NCT06429722Lead Sponsor
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
PHASE2Completed
18 participants
Started: May 13, 2024 · Completed: May 30, 2025
NCT06058039Lead Sponsor
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
PHASE3Recruiting
332 participants
Started: Dec 21, 2023 · Completed: Mar 31, 2026
NCT06058013Lead Sponsor
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
PHASE3Recruiting
332 participants
Started: Dec 20, 2023 · Completed: Jun 30, 2026
NCT06029439Lead Sponsor
Study to Assess the Safety and Effectiveness of NMRA-335140-501
PHASE3Recruiting
1,000 participants
Started: Nov 10, 2023 · Completed: Jun 30, 2027
Locations (1)
Headquarters
Watertown, MA, United States
Map
Loading map...